Intravenous medicine carrier material and its prepn process

A carrier material, intravenous drug technology, applied in the direction of non-active components of polymer compounds, etc., can solve problems such as limited application scope, and achieve the effects of easy to master, standardized equipment, and widely available sources.
CN101088564AInactive Publication Date: 2007-12-19李潮
0 Cites 2 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
李潮
Publication Date
2007-12-19
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
Patent Text Reader

Abstract

The present invention relates to intravenous medicine carrier material and its preparation process. The intravenous medicine carrier material is medicine release controlling material to avoid the fast removing of medicine from blood, and has itself no pharmacological effect. It is prepared with gelatin as base material, and through degrading gelatin in enzyme solution, cross-linking with cross-linking agent, purifying and drying. It has intravenous medicine release controlling effect, no toxicity, and other advantages.
Need to check novelty before this filing date? Find Prior Art

Description

(1) Technical field

[0001] The invention relates to a drug auxiliary material, which belongs to a drug carrier material which has no pharmacological effect and can slow down the rapid removal of protein drugs from blood and a manufacturing method thereof. (2) Technical background

[0002] Some intravenous injection drugs have positive therapeutic effects, but due to the rapid rise and fall of the blood concentration of the drug after administration, the drug is maintained at the therapeutic concentration level for a short time, and the therapeutic effect is limited; at the same time, the side effects caused by the increase of the blood concentration The risk is increased by this. The kinetic characteristics of this class of drugs clearly hinder their clinical application.

[0003] In order to reduce the risk caused by excessive drug blood concentration, the main preventive measure in clinical treatment is to control the dosage, but the price is to reduce the therapeutic eff...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More